Atlas Trials

Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease

Clinical trial NCT01732718 · COMPLETED

Trial details

NCT number
NCT01732718
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell DiseaseSickle Cell Nephropathy
Start date
2013-09-01
Primary completion
2018-01-09
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.